
|Articles|May 1, 2006
- Pharmaceutical Executive-05-01-2006
- Volume 0
- Issue 0
Pharm Exec 50: The World's Top 50 Pharmaceutical Companies
Changing Landscapes: A Special Report on the World?s Top 50 Pharma Companies
Advertisement
Articles in this issue
over 20 years ago
More Than a Game of Keep Awayover 20 years ago
Teamsters v. Pfizerover 20 years ago
Leadership: It is Personalover 20 years ago
Legal: The Kickback Effectover 20 years ago
Washington Report: Opportunity Knocksover 20 years ago
From the Editor: Mixed Signalsover 20 years ago
Medicare Part D: D for Doomed?over 20 years ago
Thought Leader: Scientific Expressionover 20 years ago
Opinion: Brussels Sproutsover 20 years ago
Global Report: A Hope and a PayerAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Agentic AI Revolution in Biopharma
2
Novartis Investors Share Concerns Over M&A Strategy: Report
3
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
4
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
5




